| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |